Literature DB >> 29728763

Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma.

Kai Wang1,2, Xiao Qu1, Shaorui Liu1, Xudong Yang1, Fenglong Bie1, Yu Wang1, Cuicui Huang1, Jiajun Du3,4.   

Abstract

PURPOSE: F-box proteins, as components of the Skp1-Cullin 1-F-box protein (SCF) E3 ubiquitin ligase, can specifically bind to substrates and regulate multiple tumor behaviors. However, the role of F-box proteins in squamous-cell lung carcinoma (SqCLC) has not been established.
METHODS: We identified the differentially expressed F-box protein-encoding genes in SqCLC by analyzing data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Prognosis data were evaluated using the Kaplan-Meier (KM) plotter website. The FBXO5 and FBXO45 mRNA levels were analyzed by real time RT-PCR. The impact of the inhibition of these genes with si-RNA on apoptosis and migration was also investigated.
RESULTS: The FBXO45 and FBXO5 genes were significantly up-regulated in SqCLC compared with normal lung (p values = 0.002 and 0.025, respectively). FBXO45 was significantly elevated in each tumorigenic step, including dysplasia, in situ and SqCLC. The RT-PCR analysis results showed that FBXO5 and FBXO45 were elevated in cancer tissues (p values = 0.024 and 0.004, respectively). Overexpression of FBXO5 and FBXO45 was associated with shorter overall survival (OS) in the SqCLC patients from the K-M plotter database [FBXO5 HR: 1.53 (1.03-2.28), p = 0.036]; [FBXO45 HR: 1.47 (1.03-2.08), p = 0.030]. The GO and KEGG pathway analysis showed that FBXO5 and FBXO45 were associated with cell cycle and adhesion, respectively. Knockdown of FBXO5 leads to increased apoptosis, while knockdown of FBXO45 facilitates the process of epithelial-mesenchymal transition (EMT).
CONCLUSIONS: Our results provide evidence that FBXO45 and FBXO5 may play a key role in tumorigenesis and prognosis of SqCLC.

Entities:  

Keywords:  Apoptosis; Bioinformatics; F-Box proteins; Prognosis; Squamous cell lung cancer

Mesh:

Substances:

Year:  2018        PMID: 29728763     DOI: 10.1007/s00432-018-2653-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  45 in total

1.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

Review 2.  Protein quality control and elimination of protein waste: the role of the ubiquitin-proteasome system.

Authors:  Ingo Amm; Thomas Sommer; Dieter H Wolf
Journal:  Biochim Biophys Acta       Date:  2013-07-10

Review 3.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

4.  A pathology atlas of the human cancer transcriptome.

Authors:  Mathias Uhlen; Cheng Zhang; Sunjae Lee; Evelina Sjöstedt; Linn Fagerberg; Gholamreza Bidkhori; Rui Benfeitas; Muhammad Arif; Zhengtao Liu; Fredrik Edfors; Kemal Sanli; Kalle von Feilitzen; Per Oksvold; Emma Lundberg; Sophia Hober; Peter Nilsson; Johanna Mattsson; Jochen M Schwenk; Hans Brunnström; Bengt Glimelius; Tobias Sjöblom; Per-Henrik Edqvist; Dijana Djureinovic; Patrick Micke; Cecilia Lindskog; Adil Mardinoglu; Fredrik Ponten
Journal:  Science       Date:  2017-08-18       Impact factor: 47.728

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 6.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

Review 7.  Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.

Authors:  Corey J Langer; Coleman Obasaju; Paul Bunn; Philip Bonomi; David Gandara; Fred R Hirsch; Edward S Kim; Ronald B Natale; Silvia Novello; Luis Paz-Ares; Maurice Pérol; Martin Reck; Suresh S Ramalingam; Craig H Reynolds; Mark A Socinski; David R Spigel; Heather Wakelee; Carlos Mayo; Nick Thatcher
Journal:  J Thorac Oncol       Date:  2016-08-26       Impact factor: 15.609

Review 8.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

Review 9.  Regulating Fbw7 on the road to cancer.

Authors:  Wenshan Xu; Lyudmyla Taranets; Nikita Popov
Journal:  Semin Cancer Biol       Date:  2015-10-13       Impact factor: 15.707

10.  Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.

Authors:  Maria Schwaederle; Sheryl K Elkin; Brett N Tomson; Jennifer Levin Carter; Razelle Kurzrock
Journal:  Cell Cycle       Date:  2015-06-01       Impact factor: 4.534

View more
  13 in total

1.  An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 pathway.

Authors:  Mo Wang; Chunqing Yang; Xiaobai Liu; Jian Zheng; Yixue Xue; Xuelei Ruan; Shuyuan Shen; Di Wang; Zhen Li; Heng Cai; Yunhui Liu
Journal:  J Cell Mol Med       Date:  2020-05-05       Impact factor: 5.310

2.  Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer.

Authors:  Jian Zhang; Yiping Zhou; Bo Zhang; Chunguo Wang; Baofu Chen; Haitao Ma
Journal:  J Gastrointest Oncol       Date:  2021-12

3.  Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation.

Authors:  Qi Wang; Linhui Wu; Ruoxue Cao; Jing Gao; Damin Chai; Yanzi Qin; Li Ma; Shiwu Wu; Yisheng Tao; Jia Ma; Zhi-Wei Wang
Journal:  Oncogene       Date:  2022-09-20       Impact factor: 8.756

4.  CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma.

Authors:  Tong Cao; Yue Cui; Yingying Wang; Linhui Wu; Ke Yu; Kai Chen; Jun Xia; Yuyun Li; Zhiwei Peter Wang; Jia Ma
Journal:  Apoptosis       Date:  2022-08-29       Impact factor: 5.561

5.  Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.

Authors:  Peng Liu; Xiaojuan Wang; Lili Pan; Bing Han; Zhiying He
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 6.  The role of Fbxo5 in the development of human malignant tumors.

Authors:  Junjie Gao; Dandan Yang; Ruoxue Cao; Hua Huang; Jia Ma; Zhiwei Wang; Jun Xia; Xueshan Pan
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

7.  DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1.

Authors:  Hye-Youn Kim; Young-Mi Kim; Suntaek Hong
Journal:  Cell Death Dis       Date:  2021-05-08       Impact factor: 8.469

Review 8.  Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers.

Authors:  Yizuo Song; Min Lin; Yi Liu; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Stem Cell Res Ther       Date:  2019-04-18       Impact factor: 6.832

9.  Downregulated F-Box/LRR-Repeat Protein 7 Facilitates Pancreatic Cancer Metastasis by Regulating Snail1 for Proteasomal Degradation.

Authors:  Liang Tang; Meng Ji; Xing Liang; Danlei Chen; Anan Liu; Guang Yang; Ligang Shi; Zhiping Fu; Chenghao Shao
Journal:  Front Genet       Date:  2021-06-24       Impact factor: 4.599

Review 10.  FBXO45 is a potential therapeutic target for cancer therapy.

Authors:  Min Lin; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Cell Death Discov       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.